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ABSTRACT 
 
Membrane emulsification is a relatively new technique for the highly controlled production 
of particulates. This review focuses on the recent developments in this area, ranging from 
the production of simple oil-in-water (O/W) or water-in-oil (W/O) emulsions to multiple 
emulsions of different types, solid-in-oil-in-water (S/O/W) dispersions, coherent solids 
(silica particles, solid lipid microspheres, solder metal powder), and structured solids (solid 
lipid microcarriers, gel microbeads, polymeric microspheres, core-shell microcapsules and 
hollow polymeric microparticles). Other emerging technologies that extend the capabilities 
into different membrane materials and operation methods (such as rotating membranes, 
repeated membrane extrusion of coarsely pre-emulsified feeds) are introduced. The results 
of experimental work carried out by cited researchers in the field together with those of the 
current authors are presented in a tabular form in a rigorous and systematic manner. These 
demonstrate a wide range of products that can be manufactured using different membrane 
approaches. Opportunities for creation of new and novel entities are highlighted for low 
throughput applications (medical diagnostics, healthcare) and for large scale productions 
(consumer and personal products). 
 
Keywords: membrane emulsification;  microchannel emulsification; microencapsulation; 
multiple emulsions; polymer microspheres. 
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1. Introduction 
 
The first investigation on using membrane emulsification can be traced back to the later 
1980s when Nakashima and his colleagues [1] fabricated a particular glass membrane, 
called Shirasu Porous Glass (SPG), and successfully produced highly uniform-sized 
kerosene-in-water and water-in-kerosene emulsions [2-4]. Since this time the method has 
continued to attract attention due to its effectiveness in producing narrow droplet size 
distributions at low energy consumption. Although the majority of investigations on using 
membrane emulsification have been undertaken by Japanese workers, other novel research 
is being carried out in European countries [5-9]. To date, in addition to experimentation 
using SPG membranes, investigations of a broad range of other types of membranes, such 
as ceramic, metallic, polymeric and microengineered devices, have been reported (Table 
1). The table indicates the form of the membrane, the nature of its surface, mean pore size 
and a typical effective membrane surface area deployed in the example cited in the table. 
Other types of porous materials can also be utilized such as silicon-based microfabricated 
channel devices with linear pores [29, 30] or microgrooves [31] on a single-crystal silicon 
chip and microfluidic devices of quartz glass [32] and PDMS [33]. The silicon-based 
channel devices with microgrooves and microfluidic devices are not considered in Table 1.  
 
Table 2 illustrates the wide range of application areas of membrane and microchannel 
emulsification that have been developed from simple food spreads to complex colloidal 
assemblies manufacture. Examples of particulate products manufactured using membranes 
and microchannels are shown schematically in Figure 1. It can be seen that the methods 
afford the production of a variety of structure particulate materials by means of sequential 
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secondary reactions/processes in the emulsified droplets, such as polymerisation, gelation, 
evaporation, freeze-drying, solidification, crystallization, droplet swelling, etc (Table 2). 
These processes can be used individually or in combination (e.g. evaporation or drying 
followed by crystallization or droplet swelling followed by polymerisation). 
 
A general flowsheet for manufacture of particulate products via membrane emulsification 
routes is shown in Figure 2. Depending on the membrane hydrophilicity/hydrophobicity 
and the compositions of the two liquid phases, O/W, W/O or M/W emulsions may be 
produced. The single emulsion can be subjected to secondary emulsification to form a 
multiple emulsion or may undergo a process/reaction converting the droplets into solid 
particles or the continuous liquid phase into a solid phase. For example, non-aqueous 
droplets can be converted to polymer microspheres by heat-induced polymerisation (if they 
contain a monomer mixture) or by solvent evaporation (if they are composed of a pre-
formed polymer dissolved in a volatile solvent). The oil droplets can be made up of a high 
melting-point oil and can be transformed into solid particles by cooling. Similarly, the hot 
droplets of a metal solder can be solidified to produce fine solder powder. The aqueous 
droplets can also be subjected to a number of solidification processes, depending on their 
formulation, such as gelation, polymerisation, crystallization, heat coagulation, etc.    
 
It has been stated that the development of emulsification methods must be rooted in one of 
two possible manufacturing approaches [76]: (a) reduction of process length scales of the 
turbulent perturbations and enhancement of their uniformity in the mixing processes that 
rupture the liquids, and (b) manufacture of droplets individually (drop-by-drop) using 
micro-engineered structured systems. Membrane and microchannel emulsification, in 
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which the production of emulsions is achieved by the droplets extruding from the outlet of 
many individual pores or microchannels, represents a typical example of the second 
approach. This paper aims to introduce the latest development on the utilisation of the 
membrane emulsification technique following on from some of our earlier investigations 
on using this technique for manufacture of emulsion dispersions. The physical principles of 
the process will be discussed in detail. Experimental work carried out by the authors and 
other researchers on exploring the boundaries of this unique technique will be reviewed.  
 
The dispersity of the droplets throughout this paper will be expressed in terms of the 
coefficient of variation (relative standard deviation) or the relative span factor. For a 
specific size distribution the coefficient of variation is defined as CV = (σ/dav) × 100, 
where σ is the standard deviation of the droplet diameters and dav is the number-average 
mean droplet diameter. The relative span factor (or span) is defined as (d90−d10)/d50, where 
dx0 is the diameter corresponding to x0 vol. % on a relative cumulative droplet diameter 
distribution curve.  
 
2. Principles and Process Systems for Membrane Emulsification  
 
Membrane emulsification (ME) methods reported so far in the literature are depicted 
schematically in Fig. 3. In conventional direct ME (Fig. 3 (a)), fine droplets are formed in 
situ at the membrane/continuous phase interface by pressing a pure disperse phase through 
the membrane. In order to ensure a regular droplet detachment from the pore outlets, shear 
stress is generated at the membrane/continuous phase interface by recirculating the 
continuous phase using a low shear pump (Fig. 4 (a)) [2] or by agitation in a stirring vessel 
-6- 
[77] (Fig. 4 (b)). The rate of mixing should be high enough to provide the required 
tangential shear on the membrane surface, but not too excessive to induce further droplet 
break up. Another approach uses systems equipped with a moving membrane, in which the 
droplet detachment from the pore outlets is stimulated by rotation [16] or vibration [78] of 
the membrane within a stationary continuous phase (Fig 4 (c)). Even in the absence of any 
tangential shear, droplets can be spontaneously detached from the pore outlets at small 
disperse phase fluxes (Fig. 4 (d)), particularly in the presence of fast-adsorbing emulsifiers 
in the continuous phase and for a pronounced non-circular cross section of the pores [30]. 
This type of behaviour is similar to the interfacial tension driven-droplet formation process 
observed in grooved microchannel (MC) emulsification [79]. 
 
A potential disadvantage of direct ME is the relatively low maximum disperse phase flux 
through the membrane of typically 0.01-0.1 m3/(m2h), that has to be restrained to avoid the 
transition from a ‘size-stable’ to ‘continuous outflow’ zone [30] and to avoid the steric 
hindrance among droplets that may be formed simultaneously at the adjacent pores [7]. It 
is observed that the formation of uniform droplets is only possible within the size-stable 
zone, in which the mean droplet size is almost independent on the disperse phase flux and 
wall shear stress [80]. In the ME studies with a microsieve [7] and SPG membranes [81] 
the disperse phase flux was 2.5 m3/(m2h), but polydisperse droplets were obtained. Due to 
the low productivity, i.e. long production times, direct ME is more suitable for the 
preparation of relatively diluted emulsions with disperse phase contents up to 30 vol. %. 
Nevertheless, this process enables to obtain very narrow droplet size distributions to be 
produced over a wide range of mean droplet sizes. In the case of SPG emulsification [82-
86], the mean droplet size of both O/W and W/O emulsions can range from less than 1 µm 
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to over 60 µm, with the relative span factors under optimal conditions of 0.26-0.45. For 
ceramic membranes the droplet size range can be 0.2-100 µm with a range of spans [87].  
 
Suzuki et al. [88] implemented ‘premix’ ME, in which a preliminarily emulsified coarse 
emulsion (rather than a single pure disperse phase) is forced through the membrane (Fig. 3 
(b)). This is achieved by mixing the two immiscible liquids together first using a 
conventional stirrer mixer, and then passing this preliminarily emulsified emulsion through 
the membrane. If the disperse phase of feed emulsion wets the membrane wall and suitable 
surfactants are dissolved in both liquid phases, the process may result in a phase inversion, 
i.e. a coarse O/W emulsion may be inverted into a fine W/O emulsion (Fig. 3 (c)) and vice 
versa [20]. The main advantage of this method is that a fine emulsion can be easily 
prepared from a low concentration coarse emulsion at high rates. For a PTFE membrane 
used by Suzuki et al. [20], the maximum disperse phase content in the phase-inverted 
emulsions was 0.9 and 0.84 for O/W and W/O emulsions, respectively. Flow-induced 
phase-inversion (FIPI) phenomenon was investigated earlier by Akay [89] using a multiple 
expansion-contraction static mixer (MECSM), which is a series of short capillaries with 
flow dividers, and by Kawashima et al. [90] using hydrophobic polycarbonate membranes 
with a mean pore size of 3 and 8 μm. Kawashima et al. [90, 91] inverted a W/O/W 
emulsion consisting of liquid paraffin, Span 80 and Tween 20 into a semisolid W/O 
emulsion. This W/O emulsion was redispersed into an aqueous solution of hydrophilic 
surfactant to form W/O/W emulsion containing smaller and more uniform internal droplets 
than the original W/O/W emulsion. 
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Premix ME holds several advantages over ‘direct’ ME: the optimal transmembrane fluxes 
with regard to droplet size uniformity are typically above 1 m3/(m2h), which is 1-2 orders 
of magnitude higher than in direct ME; the mean droplet sizes that can be achieved using 
the same membrane and phase compositions are smaller than in direct ME, which can be 
advantageous; the experimental set-up is generally simpler than in direct ME, e.g. no 
moving parts such as cross-flow pump or stirrer are needed, except for the preparation of 
pre-emulsion, and finally; the premix ME process is easier to control and operate than 
direct ME, since the driving pressure and emulsifier properties are not so critical for the 
successful operation as in the direct ME process. 
 
In the first premix ME study [88] a cross-flow system was used, in which the coarse 
emulsion was diluted by permeation into pure continuous phase/diluted emulsion 
recirculating at the low-pressure side of the membrane. In the subsequent works (Table 3), 
a dead-end system was used, in which the fine emulsion was withdrawn as a product after 
passing through the membrane, without any recirculation and/or dilution with the 
continuous phase. It enables fast preparation of emulsions with a disperse phase content of 
50 vol. % or more [92]. One of the disadvantages of premix ME is a higher droplet 
polydispersity compared to direct ME. In order to combine the advantages of both 
techniques, i.e. high throughput of premix ME and narrow droplet size distribution of 
direct ME, a multi-pass (repeated) premix ME was attempted [21-22, 27, 92]. In this 
process, the fine emulsion is repeatedly passed through the same membrane a number of 
times to achieve additional droplet size reduction and enhance size uniformity (Table 3). 
 
3. Particle Manufacture 
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There have been a few review papers available in the literature, describing various novel 
techniques for making emulsions and particulates. Williams [76] listed some of the 
engineering and technological challenges which could be facing researchers in 
manufacturing "designer particles" in large quantities. For example, for droplets between 
10-100 µm microchannel (MC) emulsification process has, in particular, been considered 
an effective method of producing uniform particles, with typical coefficients of variation of 
5% (this compares with normal CVs of about 10% for other membranes). The current state 
of membrane emulsification technology and the underlying process phenomena have been 
reviewed by several authors [93-96]. These articles are mainly focused on the influence of 
process parameters and membrane properties on the droplet size distribution and the 
transmembrane flux. Until now, however, a broad range of particulate products that can be 
produced by utilising this technique have not been presented in a systematic manner.  
 
3.1 Single emulsion production 
 
Single emulsion production by direct method is still the most investigated system for 
membrane emulsification applications. Table 4 lists some of the case studies recently 
reported in the literature. To allow continuous and optimal production of monodispersed 
emulsions, the affinities between the membrane surface, disperse and continuous phases 
and the electrical charge on the functional groups of emulsifiers must be considered 
carefully. For a preparation of O/W emulsions, hydrophilic membranes must be used. This 
avoids the wetting and spreading of the disperse phase (i.e., oil) on the membrane surface. 
Similar principles may also apply to the choice of the emulsifiers. The functional groups of 
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the chosen emulsifiers must not carry the charge opposite to that of the membrane surface 
in order to facilitate the membrane surface retaining its hydrophilicity. For example, an 
untreated SPG membrane has a negative surface potential of -15 to -35 mV within the pH 
range of 2 to 8, due to the dissociation of acid silanol groups [101]. Hence for the above 
O/W case, use of cationic emulsifiers such as CTMABr or TOMAC must be avoided. The 
same conclusion holds for emulsification using silicon MCs [30].  
 
For a preparation of W/O emulsions, hydrophobic membranes and MCs must be used. The 
SPG membrane and silicon MCs are inherently hydrophilic. Hydrophobic treatment of 
SPG membranes can be successfully carried out by coating the membrane surface with a 
silicone resin. It was recently shown that even in the submicron range of mean pore sizes 
the membrane resistance was unaffected by this treatment, which means that the pores 
were not plugged by the resin [102]. However care does has to be taken in this silinisation 
process to avoid blockages. 
 
3.2 Production of multiple (complex) emulsions 
 
Production of so-called multiple emulsion involves the preliminary emulsification of two 
phases (e.g., W/O, O/W or E/O), followed by secondary emulsification into a third phase 
leading to a three phase mixture, such as W/O/W, O/W/O or E/O/W. The primary 
emulsion is usually prepared under intense homogenisation conditions to obtain as fine 
internal droplets as possible. The secondary emulsification step is carried out under less 
severe conditions in order to avoid rupture of the liquid membrane between the internal 
disperse phase and continuous phase of the multiple emulsion. If the second step is carried 
out using a conventional emulsification device, the external droplets are in most cases 
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highly polydisperse or the entrapment efficiency is very small. Membrane or MC 
emulsification enables to obtain narrow size distribution of the external droplets, and yet to 
maintain a high encapsulation yield of the internal droplets [49]. 
 
3.2.1 Water-in-oil-in-water emulsions 
The W/O/W type of emulsions is particularly important to the pharmaceutical industry to 
initiate contained and targeted drug delivery [35]. The W/O/W emulsions were prepared in 
two steps. A submicron W/O emulsion was first prepared using a hydrophobic membrane 
or conventional rotor stator emulsification device. The water phase contained an anticancer 
drug (epirubicin), and the oil phase was made up of an iodised poppy seed oil (Lipiodol) 
with polyoxyethylene (40) hydrogenated caster oil being used as the hydrophobic 
surfactant. This was then followed by further emulsification using a hydrophilic membrane 
and the W/O emulsion as the disperse phase. Clinical trials showed that the multiple drug 
emulsion, when administered directly into the liver via the hepatic artery, was effective in 
contracting the liver cancer texture. It was concluded that ME enabled the design of a 
controlled release vehicle at a much higher production yield in comparison with other 
traditional methods. Mine et al.'s study [103] revealed that to make a stable W/O/W 
emulsion, the concentration of internal water droplets must be between 30 and 50 % (v/v), 
and the membrane pore size for the second step emulsification must be no less than twice 
the diameter of the internal droplets.  
 
Multiple emulsions can also be produced using a MC plate in much the same way as that 
done using a porous membrane. Kawakatsu et al. [40] and Sugiura et al. [104] investigated 
production of W/O/W emulsions by MC emulsification. The emulsions were prepared by 
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first homogenising a mixture of water and oil phase using a conventional homogeniser. 
The W/O emulsion thus obtained was then forced through the MC device into a second 
water phase containing a suitable emulsifier for oil phase stabilisation. The monodispersed 
droplets of W/O emulsion were prepared using 5 wt. % tetraglycerine polyricinolate 
dissolved in MCT, decane or ethyl oleate as the oil phase [104]. The oil film between the 
two water phases was not broken when the internal droplets larger than the MCs penetrated 
through the channels. The internal water droplets larger than the resulting W/O/W droplets 
were divided into several smaller droplets before being penetrated through the channels. 
The low shear stress conditions during secondary emulsification led to a high entrapment 
efficiency estimated to be of 91 %. 
 
3.2.2 Oil-in-water-in-oil emulsions and spreads 
Okonogi et al. [38] developed a method for producing a O/W/O type edible emulsion, 
which involved dispersing an O/W emulsion into a fatty phase through a hydrophilic 
microporous glass membrane which has been rendered hydrophobic by the pre-immersion 
into the fatty phase. An O/W/O type spread can be manufactured by rapidly cooling and 
kneading the O/W/O emulsion consisting primarily of plastic oils, aqueous solution, and 
emulsifiers. The fatty phase constituents preferably 25 to 75 % of the final product, and the 
external oil phase preferably 20 % and more of the total fatty phase. The authors suggested 
that using membrane emulsification technology for the production of W/O type low-fat 
spread and O/W/O type spread, it was possible to reduce the amount of fatty phase in the 
whole compositions to 20 % for the W/O type spread and 25 % for the O/W/O type spread 
in comparison with other traditional methods, without using stabilizers and gelling agents 
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as essential ingredients. To date these methods have not been widely implemented on an 
industrial scale. 
 
3.2.3 Ethanol-in-oil-in-water emulsions 
Nakajima et al. [39] patented functional emulsions for use in food, drugs and cosmetics, 
consisting of ethanol as a disperse phase and oil as a continuous phase (E/O) or ethanol-in-
oil emulsion as a disperse phase and water as a continuous phase (E/O/W). An ingredient 
which is insoluble or having a low solubility in water and oil (e.g. polyphenols, taxol, 
androstenedione, validamycin, etc) is dissolved in ethanol at the concentration of 20-30 % 
and the ethanol solution is then dispersed into oil phase using a conventional homogeniser 
or membrane/MC emulsification. The E/O emulsion can be further dispersed into water 
phase to produce E/O/W multiple emulsions with a wide range of applications as emulsion 
delivery systems in food, drugs and cosmetics. 
 
3.3 Production of solid-in-oil-in-water dispersions 
 
Toorisaka et al. [41] prepared a S/O/W dispersion for oral administration of insulin by 
passing a preliminary emulsified S/O/W dispersion several times (usually three) through a 
SPG membrane with a mean pore size of 1.1 µm. The S/O suspension containing 
surfactant-coated insulin dispersed in soybean oil was first mixed with aqueous solution 
containing a hydrophilic surfactant (sugar ester L-1695), sodium cholate and d-glucose to 
prepare a coarse S/O/W dispersion using a conventional rotor stator homogeniser. The 
coarse S/O/W dispersion was then homogenised by passing through the SPG membrane to 
prepare a monodispersed emulsion with the mean droplet size of 1.0 µm. The surfactant-
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coated insulin was prepared by mixing an aqueous solution of insulin with a hexane 
solution containing a lipophilic surfactant (sugar ester ER-290), followed by freeze-drying. 
The S/O/W dispersion showed the hypoglycemic activity for a long period after oral 
administration to rats, owing to the conversion of insulin into a lipophilic complex and 
uniform droplets of S/O suspension [41]. 
 
Supsakulchai et al. [67] prepared S/O/W dispersions by extruding S/O suspensions 
containing fine particles of anatase-type titanium dioxide in poly(St-co-AA)-toluene 
solutions through the SPG membrane into an aqueous phase containing dissolved PVA and 
SDS. The polymer microcapsules containing 10-20 wt. % of TiO2 were prepared from the 
S/O/W emulsions by vacuum evaporation of toluene. In this study, the SPG membrane 
emulsification process failed to yield uniform capsules due to some wetting problems. 
 
Kawakatsu et al. [40] investigated the preparation of S/O/W pectin microcapsules by MC 
emulsification. The microcapsules were prepared by first homogenising a water phase (0.5 
wt. % pectin solution) and oil phase (3 wt. % TGCR in oleic acid) using a conventional 
homogeniser. The W/O emulsion was then forced through a MC plate into the second 
water phase containing CaCl2 and Tween 20. The W/O/W emulsion was converted into a 
S/O/W dispersion by gelation of the internal water droplets due to interfacial reaction 
between pectin macromolecules and calcium ions.  
 
3.4 Production of coherent solids  
 
3.4.1 Silica micro- and nanoparticles 
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Silica micro- and nanoparticles find numerous uses as catalysts, coatings, stiffeners, 
binders, polishing agents for silicon wafers, absorbents, thickeners, reinforcing agents in 
organic polymers, etc. Kandori et al. [43] prepared silica microparticles by first adjusting 
the pH of a sodium silicate solution to 2.0 with 2.3 M sulphuric acid and then extruding the 
acidic sodium silicate solution through the SPG membrane into 2-10 wt. % solution of PE-
64 surfactant in toluene. To avoid polymerisation of silicic acids before emulsification, the 
acidic sodium silicate solution was prepared just prior to its use. The obtained sodium 
silicate droplets were converted into silica hydrogel particles by gently mixing the W/O 
emulsion for 7 days at room temperature. Using the SPG membranes with a mean pore size 
of 0.98 and 2.7 µm, the silica hydrogel particles with a mean size of 0.9-1.3 µm were 
prepared, which was 63-86 % of the mean droplet size in the W/O emulsion before 
polymerisation. Yanagishita et al. [13] prepared silica nanoparticles using an anodic 
porous alumina membrane with uniform pores of 125 nm diameter. 1 M aqueous sodium 
silicate solution was forced through the hydrophobic membrane into a mixture of hexane 
and cyclohexane containing 2.5 wt. % Tween 85. The resultant W/O emulsion was added 
to an aqueous ammonium carbonate solution and the mixture was agitated at 40 °C for 8 
hours to solidify the sodium silicate droplets by interfacial polymerisation of silicic acids. 
The mean size of the silica particles was 70 nm and the CV was 26 %.   
 
3.4.2 Metal solder particles 
Uniform solder microparticles are increasingly in demand for surface mount technology in 
the electronics industry. This is a method of assembling printed circuit boards where the 
components are mounted onto the surface of the board rather than being inserted into holes 
in the board. Shimizu et al. [42] manufactured solder microparticles by a temperature-
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controlled SPG membrane emulsification at 80-200 °C. Liquid solder metal was dispersed 
into an aqueous solution of SDS using a hydrophilic SPG membrane to form a metal-in-
water (M/W) emulsion. Alternatively, hot liquid metal was extruded through a 
hydrophobic SPG membrane into an organic phase composed of TGCR, lead stearate or 
stearic acid dissolved in kerosene, paraffin or toluene. Fine solder particles were obtained 
by quenching the resulting M/W or M/O emulsion.  
 
3.4.3 Solid lipid microspheres 
Production of solid lipid microspheres by MC emulsification was investigated by Sugiura 
et al. [44] and Kobayashi et al. [45]. In Sugiura et al.'s study, microspheres were produced 
by a temperature-controlled MC emulsification process and subsequent solidification of the 
whole disperse phase (a high melting point edible oil), while in Kobayashi et al.'s study, 
lipid microparticles were produced by solvent evaporation method. In the former case, 
tripalmitin or hydrogenated fish oil with the melting points of 58 °C penetrated through the 
MCs into an aqueous solution of emulsifier at 70 °C and an O/W emulsion with an average 
droplet diameter of 21 µm and the CV of 4 % was obtained. Solid lipid microspheres with 
the same size and uniformity were formed by cooling and freeze-drying of the O/W 
emulsion. In the study of Kobayashi et al. [45], the oil phase (0.1-1 vol. % tripalmitin 
dissolved in hexane) was dispersed into the continuous water phase (1 wt. % SDS or 
pentaglycerol monolaurate) by MC emulsification at room temperature. The average 
diameter of oil droplets was 10-11 µm and the CV was below 8 %. Solid microspheres 
with an average diameter of 1-3 µm and the CV of 20 % were produced by evaporation of 
organic solvent under atmospheric pressure and room temperature for 24 h. The volume 
ratio of oil droplets with respect to solid microspheres corresponded well to the volume 
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ratio of the whole oil phase with respect to tripalmitin. It should be noted here that solvent 
evaporation method enables to obtain smaller, but less monodispersed lipid microspheres. 
 
3.4.4 Crystal products 
Membrane processes can be used to formulate crystal products as described elsewhere [46-
47]. A variety of systems have been used based on using the membrane as a microdisperser 
for two miscible aqueous phases and some using emulsified droplets as the microreactors 
that subsequently produce crystals as a result of changes in the chemical environment 
within the droplets. The latter process will be considered here as it is mediated by an 
emulsion phase. This type of process is suited to rate processes that are quite slow and as 
such can be regarded as two-stage processes, consisting of droplet formation in ME 
followed by crystal nucleation and growth. Work has been reported on different chemical 
systems [47] using cross flow membrane emulsification and is often referred to as XMC. A 
detailed study of the crystallization of hexadecyl palmitate has been reported in which 160 
nm crystals were obtained using an alumina ceramic membrane (0.5 µm pore size). The 
ester was dissolved in toluene and mixed with water and Tween 20, with the level of ester 
being controllable. An emulsion was formed via ME and the resultant droplets (whose size 
could be controlled) were then allowed to shrink as the toluene evaporated. Judicious 
selection of the initial ester concentration in the droplet and the size of the droplet was used 
to determine the final crystallite size. Fig. 5 shows some micrographs taken at different 
times during such a re-crystallization process and illustrates the evolution of a crystal. Here 
the timescales are set by the rate of evaporation of the solvent and proper design of XMC 
may allow this to be deployed as a specialist manufacturing route for precision 
crystallization. 
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3.5 Production of solid lipid microcarriers 
 
Nakashima [37] have reported production of three kinds of solid lipid microcarriers using 
SPG membranes. These microcarriers were particularly investigated for oral administration 
of irinotecan hydrochloride (CPT-11), which is a highly effective anticancer drug with 
unfavorable side effects. A preparation flowsheet of the so-called solid microcarrier and 
water-in-oil (W/O) carrier is similar (Figure 6). A submicron W/O emulsion containing 
more than 50 mg/l CPT-11 in aqueous solution as a disperse phase and 10 wt. % TGCR in 
tripalmitin as a continuous phase was first prepared using a conventional rotor stator 
emulsification device at 80 °C to prevent oil solidification. This was then followed by 
dispersion of the W/O emulsion in an external water phase at 80 °C by a stirrer. The coarse 
polydispersed W/O/W emulsion was homogenised by passing through the SPG membrane 
with a mean pore size of about 11 µm. The W/O microcarrier was obtained by cooling the 
W/O/W emulsion and subsequent filtration of the solidified emulsion. Figure 7 shows a 
SEM photograph of the solidified W/O particle. The estimated entrapment efficiency of 
CPT-11 in the W/O carrier was more than 90 % under optimal conditions [105].  
 
A W/O carrier for the taste improvement of raw miso paste containing droplets of an 
aqueous solution of 5'-ribonucleotide embedded in the hardened palm oil was produced in 
the similar way [37]. The solid microcarrier containing a solid drug or nutrient within a 
porous solid lipid particle was obtained by freeze-drying of the W/O/W emulsion. The 
production of solid-in-oil (S/O) microcarrier involves freeze-drying of the S/O/W 
emulsion, as shown in Figure 6.   
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3.6 Production of gel microbeads 
 
Alginate beads have been extensively used in microencapsulation because they are very 
easy to prepare on a lab-scale, the process is very mild and virtually any ingredient can be 
encapsulated [106]. However, as easy as it to make small batch using a syringe extruder 
and a stirred calcium bath, the scaling up of the process is very difficult and processing 
costs are stupendous. Weiss et al. [50] developed a ME-based process in which an aqueous 
Na-alginate solution was extruded through a hydrophobic SPG membrane into a non-
aqueous phase (2-5 % Span 80 in MCT oil) to form a W/O emulsion. The droplets were 
crosslinked by adding 3 % CaCl2 solution and the microbeads were collected by filtration. 
The process can easily be scaled up and allow formation of uniform microbeads with an 
adjustable mean size (20-300 µm), which is difficult to achieve using conventional alginate 
beads processes. Liu et al. [17] produced Ca-alginate beads with a mean size of about 55 
µm and the CV of 27 % using a nickel membrane with a mean pore size of 2.9 µm. A W/O 
emulsion containing 25 mM CaCO3 in 0.5-2 % w/v Na-alginate solution as a disperse 
phase and 1.5 % v/v Span 80 in paraffin oil as a continuous phase was prepared using the 
Ni membrane, pretreated by soaking in paraffin oil for at least 8 h. The gelation was 
initiated by the addition of glacial acetic acid into the emulsion, dissolving CaCO3 to 
release Ca2+. Iwamoto et al. [48] produced gelatin microbeads with a mean size of about 32 
µm and the CV of 7.3 % by MC emulsification. A W/O emulsion containing 5 wt. % 
gelatin in water as a disperse phase and 5 wt. % TGCR in IO as a continuous phase was 
prepared at 40 °C using hydrophobic MCs pretreated with octadecyltrichlorosilane. The 
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gelation was induced by decreasing temperature of the emulsion to 25 °C. After a slow 
gelation at 25 °C overnight, the solidification of droplets was completed at 5 °C. 
 
3.7 Production of albumin microspheres  
 
Albumin microspheres (AMS) have found many applications in the medical diagnosis and 
treatment in recent years. Monodisperse AMS were prepared by both chemical and thermal 
hardening methods via membrane emulsification [51-53]. A monodisperse W/O emulsion 
was first prepared by passing albumin solution through a hydrophobic SPG membrane into 
kerosene. After heating the emulsion, monodisperse AMS were prepared and the heat-
denaturing process itself did not affect their monodispersity once uniform droplets had 
been prepared. The shape and size of the albumin microspheres strongly depended on the 
concentration of the albumin solution and the heat denaturing temperature.  
 
3.8 Production of polymer microspheres 
 
The production of monodisperse polymer microspheres with the mean diameter of 1-40 
µm is becoming increasingly important as these spheres are used in many sophisticated 
applications, because of their large surface-to-volume ratio and functionality. Uniform 
polymer microspheres, hydrophilic and hydrophobic, smooth and rough, solid and hollow, 
porous and uniform, with different morphologies (spherical, hemispherical, snowman-like, 
popcorn-like, etc) with diameters ranging from several micrometers to 100 µm, were 
successfully produced using SPG membrane emulsification [75, 107, 108]. These spheres 
were investigated for use as packing materials for column chromatography techniques such 
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as gel permeation chromatography (GPC) [109], high-performance liquid chromatography 
(HPLC) [110, 111], capillary electrochromatography (CEC) [111], and size-exclusion 
chromatography [112], pH sensors [113], carriers of enzymes (glucoamylase) [114], drug 
delivery systems [65], dry and liquid toners for electrophotography [115, 116, 78], spacers 
for liquid crystal displays (LCDs) and adhesives or insulators for micro-tip circuits [117, 
118]. Fig. 8 shows PDVB spacers for LCDs, manufactured by Sekisui Chemical Industries 
Co. Ltd. using a SPG membrane emulsification technique [34]. 
 
Figure 9 shows an example of manufacture of quite large polymer beads (in the size range 
80-500 µm) manufactured using an interfacial polymerisation method [15, 51]. In this case 
the membrane used was stainless steel perforated with approximately circular pores of 140 
microns in diameter. The membrane was configured as a cylinder and rotated to create a 
so-called spinning membrane reactor [16, 49]. In this case there was relatively poor control 
of the beads but the principle of making such beads using a rotating membrane and with 
using continual recirculation of the dispersed phase (see Figure 4(c)) was achieved. 
 
3.8.1 One-stage (direct) suspension polymerisation 
In one-stage polymerisation process, an oil phase containing a monomer or a mixture of 
monomers, an initiator (BPO, AIBN or ADVN), and other potential additives (solvents, 
diluents, crosslinking agents, etc) permeates through the membrane into an aqueous 
solution of emulsifiers and stabilisers to form uniform droplets (O/W emulsion). An 
inhibitor such as NaNO2, DAP or HQ is dissolved in the aqueous phase to prevent the 
secondary nucleation of polymer particles in the aqueous phase. The suspension 
polymerisation is then carried out by transferring the emulsion into a reactor and heating it 
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to above the decomposition temperature of the initiator under mild agitation and nitrogen 
bubbling. The initial narrow droplet size distribution can be retained throughout the 
polymerization stage, if the polymerisation conditions are adequate. A broad range of 
polymer microspheres with the CV of about 10 % were produced by this method using 
SPG membrane (Table 5). Although a further classification is needed to obtain particles 
with the CV value of 4 %, which is a minimum requirement for LCD spacers, the 
classification step is less complicated and cheaper than for microspheres with a broad size 
distribution prepared by a conventional suspension polymerisation [117]. 
 
The polymer beads may be made porous by the inclusion of crosslinking agents (DVB for 
PSt and EGDMA for PMMA) and adequate diluents (poor solvents for the base polymer 
constituting a network) in the oil phase. The diluents (alkanes, middle-chain alcohols, etc) 
stimulate a micro-phase separation during polymerisation, resulting in the formation of a 
porous structure. Trifunctional crosslinker TMPTMA was included in the monomer phase 
to improve the compressive strength of the particles by increasing the crosslink density, so 
that the microspheres could be used as spacers for LCDs [117]. Acrylic acid was added to 
incorporate carboxyl groups to immobilize enzymes, and GMA was used to introduce 
spacer arms [114]. Colouring and charge control agents were incorporated in the monomer 
phase to prepare toner particles with the desirable coloring and triboelectric discharging 
properties [78]. TiO2 fine particles may also be included as fluorescent whitening agents to 
improve whiteness, brightness, and opacity of the microspheres [122]. 
 
The suspension polymerisation has also been carried out in W/O and W/O/W emulsions, as 
shown in Table 6. Ma et al. [58] investigated the production of polystyrene-polyacrylamide 
-23- 
(PSt-PAAm) composite microspheres by combining a SPG emulsification technique for 
the preparation of W/O/W emulsion and suspension polymerisation. A submicron W/O 
emulsion containing an aqueous solution of AAm dispersed in styrene was first prepared 
using an ultrasonic homogeniser. This W/O emulsion was then forced through a SPG 
membrane into the external aqueous phase to prepare a uniform W/O/W emulsion. After 
polymerisation, the PST-PAAm composite particles containing tiny spherical PAAm-rich 
microdomains within a PSt matrix were obtained. As amides can be easily hydrolyzed to 
carboxylic acids or degraded to amines, these PST-PAAm particles are suitable for use as 
immobilization media of biologically active substances such as proteins and cells. 
Nagashima et al. [59, 123] attempted production of poly(acrylamide-co-acrylic acid) 
hydrogel microspheres by polymerisation of aqueous phase droplets in a W/O emulsion. 
An aqueous mixture of monomers was dispersed into the oil phase using a hydrophobic 
SPG membranes treated with octadecyltrichlorosilane and trimethylchlorosilane. The W/O 
emulsion was then subjected to polymerisation at 70 °C to form hydrogel particles suitable 
for use in swelling-controlled drug delivery systems. When placed in the body, these 
particles absorb water or other body fluids and swell. The swelling increases the aqueous 
solvent content within the formulation as well as the polymer mesh size, enabling the drug 
to diffuse through the swollen network into the external environment.  
 
Polymer microspheres were also produced using microfabricated channel devices, as can 
be seen in Table 7. The production of PDVB microspheres using silicon microchannel 
arrays was investigated by Sugiura et al. [124, 125]. The average diameter of the prepared 
beads was 3-87 µm, depending on the geometry of the MC plate used, and a CV of 4-7 % 
was lower than for the beads produced via ME (Tables 5 and 6). The additional advantage 
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is that the production of larger beads with the diameter of over 50 µm is possible without 
droplet swelling before polymerisation. Nisisako et al. [32] produced extremely uniform 
bichromal poly(isobornyl acrylate) beads with a CV of less than 1 % by polymerisation of 
highly uniform-sized two-colored droplets prepared using a microfluidic system. These 
bichromal beads comprising a charge adjuvant may find applications in newly developed 
display media, such as photochromic gyricon display (“electronic paper”) [126].   
 
3.8.2 Two-stage suspension polymerisation (droplet swelling method) 
The strong hydrophilic nature of SPG favors the formation of uniform microspheres from 
hydrophobic monomers, such as styrenic monomers. More hydrophilic acrylate monomers 
tend to yield a wider droplet size distribution due to wetting of the SPG surface. Omi et al. 
[60] overcame this problem by adopting an Ugelstad and Mørk's swelling technique [127], 
in which primary hydrophobic droplets, mainly composed of benzene and hexadecane 
(HD), were swollen in the presence of secondary emulsion droplets consisted of MMA and 
other more hydrophilic components. Subsequent polymerization yielded PMMA spheres, 
their CV being in a comparable range as that of PS spheres. Application of the swelling 
technique to hydrophobic monomers such as styrene and DVB resulted in larger P(St-co-
DVB) spheres with the mean size ranging up to 102 µm [61]. Here, the seed droplets were 
composed of DVB, HD, and an initiator, while the secondary emulsion droplets were 
consisted of more hydrophilic components, a mixture of styrene, middle chain alcohol (C6 
to C8), dichlorobenzene, and isoamyl acetate, which promoted a degradative diffusion of 
the components [61]. 
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Table 8 lists investigations on using the swelling technique in combination with SPG 
emulsification to the preparation of polymer microspheres. The primary (seed) emulsion 
containing uniform droplets was prepared by SPG emulsification, while the secondary 
emulsion containing much smaller and more polydisperse droplets was obtained by a 
conventional rotor-stator homogenisation with a very small amount of emulsifiers (about 
0.02 wt. %). Mixing these two emulsions caused absorption of the hydrophilic monomers 
from the secondary emulsion in the primary emulsion droplets due to the degradative 
diffusion mechanism. After all the droplets in the primary emulsion virtually disappeared, 
the swollen droplets were polymerised in the same way as in a single-stage polymerisation 
process. Despite the polydispersity of the secondary emulsion, the swollen droplets retain 
the uniformity of the primary emulsion, even when their volume has been increased up to 
several thousands times due to swelling [61]. Figure 10 illustrates a schematic flowsheet 
for the manufacture of both hydrophilic and hydrophobic spheres.  
 
3.8.3 Solvent evaporation method 
ME techniques have been applied to the preparation of microspheres using an organic 
solution of a preformed polymer as a disperse oil phase. The process is not dissimilar from 
that used in XMC (above). After the uniform droplets were prepared, the volatile solvent 
such as methylene chloride, chloroform, toluene, etc was evaporated. This technique has 
been applied to manufacture polylactide (PLA) and poly(lactide-co-glycolide) (PLGA) 
biodegradable microspheres [65, 128], polystyrene-poly(methyl methacrylate) (PSt-
PMMA) composite microspheres [63, 64], and polymer microcapsules containing 
magnetite (Fe3O4) [68] or TiO2 [66] (Table 9). Also, uniform PUU particles were prepared 
by solvent evaporation from PUU-xylene droplets after the PU pre-polymer underwent a 
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chain-extending reaction at room temperature with a diamine reagent (Pz) [62]. One of the 
disadvantages of solvent evaporation is that no crosslinked polymers can be incorporated 
into microspheres [122].  
 
In the production of PLA and PSt-PMMA microspheres, the preformed polymer (PLA or a 
mixture of PSt and PMMA) was dissolved in solvent (dichloromethane) containing LOH 
or HD as a cosurfactant. The role of cosurfactant was 1) to increase the hydrophobicity of 
the oil phase, thereby preventing the membrane wall from being wetted with the disperse 
phase; and 2) to prevent the oil phase from diffusing into the aqueous phase so that the 
stability of the droplets could be maintained. LOH was found to be more efficient than HD 
in providing uniform-sized microspheres [65]. 
 
Conventionally, droplets of preformed polymer solution are prepared by agitation, rotor-
stator homogenisation, sonication, microfluidisation, etc [130, 131]. Compared with the 
traditional methods, the membrane technique can provide more uniform droplets with the 
CV of 10 %. Due to narrow size distribution, the droplets do not tend to coalesce or 
redisperse during solvent evaporation. In addition, the mean droplet size can be controlled 
easily and exactly by using SPG membranes with different mean pore sizes. 
 
3.9 Production of hollow polymer particles and core-shell microcapsules 
 
Microencapsulation is defined as the embedding of at least one ingredient (active agent or 
core) into at least one other (shell material). Two of the main capsule structures are 1) 
embedded particles (or core) in the shell of the capsule (matrix microcapsules), 2) a 
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continuous shell surrounding the core (core-shell microcapsules). Core-shell microcapsules 
are preferred if the active agent should be released slowly over a very long time. 
Microcapsules are used in many different applications in chemical, cosmetic and food 
industries. Ma et al. [69] prepared uniform core-shell microcapsules with HD as a core and 
polystyrene or poly(St-co-DMAEMA) as a shell using SPG emulsification technique and a 
subsequent suspension polymerisation. The reason for the complete encapsulation of HD 
was a much smaller interfacial tension at the polymer/aqueous phase interface than at the 
HD/aqueous phase interface. As a result, the polymer phase tends to accumulate near the 
aqueous phase forming a shell, which completely surrounds HD. When the monomer 
conversion was lower, the monomer was partitioned between HD and the PSt phase. 
Consequently, the interfacial tension at the HD/aqueous phase interface was reduced, 
resulting in the leakage of HD from the capsule and a hole was observed on the surface. 
Incorporation of DMAEMA decreased the interfacial tension between the polymer and 
aqueous phase and HD could be encapsulated completely even when monomer conversion 
was lower [69]. The core size was controlled by the HD content. By adding crosslinking 
agent (DVB), solid microspheres instead of core-shell microcapsules were formed. 
 
Hollow particles are used as opacifying plastic pigments for various coatings and gloss-
enhancing plastic pigments, as a light-weight reinforcement material, a light scattering 
material, etc [72]. Omi et al. [75] produced poly(MMA-co-EGDMA-co-2-EHA) hollow 
particles by two-stage suspension polymerisation. Uniform seed droplets composed of a 
heptane/benzene (4:1) mixture, initiator and 2-EHA were first prepared using a SPG 
membrane. This emulsion was then mixed with a fine secondary emulsion composed of 
hydrophilic monomers (MMA and EGDMA), prepared using a homogenizer. The oil phase 
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of the secondary emulsion was absorbed by the seed droplets and the swollen droplets were 
then subjected to polymerisation. Because the polymer was more hydrophilic than the 
solvents, the phase separation occurred, with the solvents localized in the center and with a 
polymer network as a shell. After the solvents were extracted, hollow particles were 
obtained. A crosslinking agent (EGDMA) and a low Tg monomer (2-EHA) were added to 
reinforce the polymer wall and to provide elasticity [75]. If a good solvent (benzene) was 
added in excess, a porous structure prevailed. Ma et al. [74] prepared poly(St-co-
DMAEMA) hollow particles by one-stage suspension polymerisation using a mixture of 
St, DMAEMA, HD and ADVN as a disperse phase and an aqueous phase containing SLS, 
PVP, and NaNO2 as a continuous phase. The preparation procedure was similar to the 
preparation of core-shell microcapsules described above.  
 
Chu et al. [70, 71] produced monodisperse termosensitive core-shell microcapsules with a 
porous PA membrane as a shell and linear-grafted PNIPAAm chains in the membrane 
pores acting as thermoresponsive gates (Figure 11). An O/W emulsion containing TDS 
monomer dissolved in a mixture of organic solvents as a disperse phase and the aqueous 
solution of emulsifier (SDS or Tween 80) and stabiliser (PVA) as a continuous phase was 
prepared by SPG emulsification. A buffer solution containing EMA monomer was then 
added to the emulsion and core-shell microcapsules with a mean pore size of 4 µm were 
formed by interfacial polymerisation [132]. Plasma-graft pore-filling polymerization was 
used to graft linear PNIPAAm chains into the pores of the microcapsule membranes. The 
prepared PNIPAAm-grafted monodisperse microcapsules with an average diameter of 
about 4 µm showed satisfactory reversible and reproducible thermoresponsive release 
characteristics. The release of both NaCl and vitamin B12 from the microcapsules was 
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slow at 25 °C and fast at 40 °C, which was due to the closed/open state of the grafted 
“gates”. 
 
When emulsification was carried out using a traditional mechanical stirring method, 
polydisperse core-shell microcapsules with an average size of about 40 µm were prepared 
[132]. For drug delivery systems, monodisperse small-sized microcapsules are more 
favorable than polydisperse large-sized microcapsules, because there is a size limit for 
particles to traverse certain organs and a small particle size minimizes any potential irritant 
reaction at the injection site. A uniform microcapsule size is important to create more 
sophisticated systems in which the drug release kinetics can be more accurately controlled. 
 
3.10 Production of colloidal assemblies 
 
The uniform-sized colloidal assemblies have a number of potential applications such as 
particles for “electronic paper” and size-exclusion chromatography, photocatalyst supports, 
model colloids for complex colloidal particles, nano-bar codes for the recognition of 
biological molecules [33]. Yi et al. [33] reported the fabrication of 3D colloidal assemblies 
with narrow size distribution, in which monodisperse PS beads with a diameter of 1 or 2 
µm were assembled into a regular arrangement. Mono-sized aqueous droplets containing 
the latex beads were first dispersed into silicon oil using a microfluidic device. Then, the 
S/W/O dispersions were converted to uniform colloidal assemblies of latex spheres by 
slowly removing water from the aqueous droplets. Similarly, Yi et al. [133] produced 
uniform 3D assemblies of sub-micrometer monodisperse colloidal particles, so-called 
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photonic balls that may be used as photonic crystals and light diffusers in a wide variety of 
applications.  
 
4. Conclusions 
 
All the investigations carried out so far show that membrane emulsification offers great 
potential in manufacturing 'made-to-measure' emulsions and other solid particulates. The 
process is reliable, and suitable to large scale productions, as scale-up is mainly based on 
multiplication of small scale processing units (e.g., membrane modules) rather than the 
simple enlargement of processing vessel sizes. Both single (W/O or O/W) and multiple 
(W/O/W, E/O/W or O/W/O) emulsions, with various droplets sizes ranging from 0.8 to 
over 100 µm, and a typical coefficient of variation of 10-15 %, have been successfully 
prepared by employing different pore sizes and types of membranes. It is envisaged that 
direct membrane emulsification can be a specially attractive technique for small scale 
manufacture of low viscosity, low concentration emulsion products, due to its high 
capability of droplet size and distribution controls but limited emulsifying rate. Premix 
membrane emulsification is a technique potentially suitable for large scale manufacture of 
high concentration emulsion products, due to high emulsifying rate and simple operation.  
 
Membrane emulsification has also been adopted for the precision manufacture of solids. 
To date, several different types of particles have been successfully produced by 
incorporating use of membranes in processes of polymerisation, gelation, crystallization, 
and encapsulation. The approach has a future potential of enabling formations of a variety 
of high specification particulates, such as ones not only with monodispersed size and 
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distributions, but also having a demanding tolerance on the particle shape, surface 
functional group and crystal orientations. The end product would be a particle suspension, 
with tailor-made chemical activities and macroscopic rheological behaviours to meet 
modern demand for 'smart' particles in a wide range of manufacture industries.  
 
Abbreviations of Chemicals 
 
AA: acrilic acid 
AAm: acrylamide 
ADVN: N,N'-azobis(2,4 
dimethylvaleronitrile) 
AIBN:  2,2’-azobis(isobutyronitrile) 
ASt: acetoxystyrene 
BA: butyl acrylate 
BAc: butyl acetate 
BANI-M: diphenylmethane-4,49-bis-
allylnagiimide 
BLG: β-lactoglobulin  
BMA: butyl methacrylate 
BPO: benzoyl peroxide 
BuOH: butanol 
Bz: benzene 
CA: cetyl alcohol 
CAS: caseinate 
CHA: cyclohexyl acrylate 
CHx: cyclohexane 
CTMABr: cetyltrimethyl ammonium 
bromide 
DAP: diaminophenylene 
DAROCUR® 1173: initiator of photo-
induced polymerisation 
DCB: o-dichlorobenzene 
DCM: dichloromethane 
DD: dodecane 
DHBSP: 2.5-dihydrozybenzenedisulfonic 
acid, dipotassium salt 
Disperbyk-111 or 180: dispersing 
additives of BYK-Chemie 
DMAEMA: dimethylaminoethyl 
methacrylate 
DOP: dioctyl phthalate 
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DVB: divinylbenzene 
EA: ethyl acetate 
EDA: ethylene diamine 
EGDMA: ethylene glycol dimethacrylate 
2-EHA: 2-ethylhexyl acrylate 
2-EHMA: 2-ethylhexyl methacrylate 
E-81: a charge control agent 
GMA: glycidyl methacrylate 
HA: hexanol 
HD: hexadecane 
HDOH: hexadecanol 
HDDA: 1,6-hexanediol diacrylate 
HEMA: 2-hydroxyethyl methacrylate 
Hp: heptane 
HQ: hydroquinone 
Hx: hexane 
IA: isoamyl acetate 
IBOA: isobornyl acrylate 
IO: Isooctane 
KPS: potassium persulfate 
LA: lauryl acrylate 
LMA: lauryl methacrylate 
LOH: lauryl alcohol 
MA: methyl acrylate 
MBAAm: N,N’-methylene-bis-
acrylamide 
MCT: medium chain triglycerides 
ML: methyl laurate 
MMA: methyl methacrylate  
4-MP: 4-methyl-2-pentanol 
MP: methyl palmitate 
MST-1: stabiliser of Nippon NSC Ltd. 
OA: octanol 
PA: polyamide 
PASt: polyacetostyrene 
PDA: p-phenylenediamine 
PDMS: polydimethylsiloxane 
PEGMMA: polyethylene glycol 
monomethacrylate 
PEGPMMA: polyethylene glycol 
polymethacrylate 
PGPG 90: polyglycerol polyricinoleate 
PIP: polyimide prepolymer 
PLA: Polylactide acid 
PMMA: polymethyl methacrylate 
PNIPAAm: poly(N-isopropylacrylamide) 
PSt: polystyrene 
PUU: polyurethaneurea 
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PVA: polyvinyl alcohol 
PVP: polyvinyl pyrrolidone 
Pz: piperazine 
SBR: styrene-butadiene rubber 
SDS: sodium dodecyl sulfate 
SLS: sodium lauryl sulfate 
Span 20: sorbitan monolaurate 
Span 60: sorbitan monostearate 
Span 80: sorbitan monooleate 
Span 85: sorbitan trioleate 
SPBS: Sumiplast Blue S (colorant) 
St: styrene 
SUNSOFT818H: oil-soluble surfactant 
t-BPP: tert-butyl peroxypivalate 
TCB: trichlorobenzene 
TDS: terephthaloyl dichloride 
TGCR: tetraglycerin condensed 
ricinoleate 
Tl: toluene 
TMEDA: N,N,N’,N’-
tetramethylethylenediamine 
TMPTMA: trimethyolpropane 
trimethacrylate 
TOMAC: tri-n-octylmethyl ammonium 
chloride 
Tween 20: polyoxyethylene (20) sorbitan 
monolaurate 
Tween 85: polyoxyethylene (20) sorbitan 
trioleate 
VP: vinyl polymer 
Xl: Xylen
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Tables 
 
Table 1: Microporous membranes other than Shirasu Porous Glass (SPG) used by different 
investigators for membrane emulsification. 
 
Membrane material Membrane form 
Inherent 
surface 
affinity 
Mean 
pore 
size 
Effective 
membrane 
area 
Ref. 
Coated α-alumina or 
zirconia Tubular Hydrophilic 
0.02-3 
µm 
50-460 
cm2 [9-12, 5] 
Anodic porous alumina Flat Hydrophilic 0.125 
µm - [13] 
Sol-gel porous glass 
(sol-gel PG) Tubular Hydrophilic 0.6 µm - [14] 
Stainless steel with 
laser drilled pores Tubular Hydrophilic 
100-150 
µm 4 cm
2 [15, 16] 
Microporous nickel Tubular Hydrophilic 2.9-5.2 
µm  - [17] 
Polypropylene Hollow fiber Hydrophobic 0.4 µm 10
3 cm2 [18]  
Polyamide Hollow fiber Hydrophilic 10 nm 36 cm
2 [8]  
Polytetrafluoroethylene 
(PTFE) Flat 
Hydrophilic 
or 
hydrophobic 
0.5-5 
µm 3-17 cm
2 [19-24]  
Polycarbonate,  
track-etched Flat Hydrophilic 
0.6-10 
µm 1.5-14 cm
2  [25, 26]  
Cellulose acetate Flat Hydrophilic 0.2-3 
µm 4 cm
2 [27] 
Microengineered 
silicone nitride 
microsieve 
Flat Hydrophilic 7 µm  3⋅10-4 cm2 [7, 28]  
Straight-through 
silicon microchannels Flat Hydrophilic 
10-17 
µm 1 cm
2 [29, 30]  
 Table 2: Secondary products of membrane and microchannel emulsification. 
 
Product type Example Secondary reaction/process after primary emulsification Ref. 
W/O spreads Stable low-fat food spreads Chilling/kneading [34]  
W1/O/W2 
emulsions 
Drug and nutrient delivery 
systems 
Emulsification of W1/O emulsion in 
external water phase W2 
[34-37]  
O1/W/O2 
emulsions Food emulsions 
Emulsification of O1/W emulsion in 
external oil phase O2 
[38]  
E/O/W 
emulsions 
Polyphenol-enriched 
emulsions 
Emulsification of E/O emulsion in 
water phase [39] 
S/O/W 
dispersions 
S/O/W pectin microcapsules Gelation of internal water phase W1 in W1/O/W2 emulsion 
[40] 
Medicine for oral 
administration of insulin 
Emulsification of S/O suspension in 
water phase [41]  
Coherent 
solids 
Solder metal microparticles Solidification of liquid metal in M/W or M/O emulsion [42] 
Silica nano- or 
microparticles 
Polymerisation of silicic acids by 
interfacial or internal reaction [13, 43] 
Solid lipid microspheres 
Solidification of oil droplets in O/W 
emulsion [44] 
Solvent evaporation from oil phase 
in O/W emulsion [45] 
Crystal products Solvent evaporation from oil droplets in O/W emulsion [46, 47] 
Structured  
solid lipid 
microcarriers 
W/O microcarrier Solidification of oil phase in W/O/W emulsion [37] 
S/O microcarrier Freeze-drying of S/O/W emulsion [37] 
Solid microcarrier Freeze-drying of W/O/W emulsion [37] 
Gel 
microbeads 
Gelatin, Ca-alginate or 
pectin microbeads 
Gelation of water droplets in W/O 
emulsion [17, 48-50] 
Protein 
microspheres Albumin microspheres 
Heat or chemical denaturation of 
protein in W/O emulsion [51-53] 
Polymeric 
microspheres 
PSt, P(St-co-DVB), P(St-co-
MMA), PUU-VP, etc. 
Direct suspension polymerisation in 
O/W emulsion [54-57, 15]  
PSt-PAAm composite Direct suspension polymerisation in W/O/W emulsion [58] 
P(AAm-co-AA) hydrogel Direct suspension polymerisation in W/O emulsion [59] 
PMMA microspheres and 
large P(St-co-DVB) spheres 
Two-stage suspension 
polymerisation in O/W emulsion [60, 61] 
PUU, PSt-PMMA, 
biodegradable PLA spheres  
Solvent evaporation from oil phase 
in O/W emulsion  [62-65] 
TiO2/Fe3O4 embedded 
Solvent evaporation from oil phase 
in S/O/W emulsion [66-68] 
Polymeric 
core-shell 
microcapsules 
and hollow 
particles 
P(St-co-DMAEMA) 
microcapsules 
Suspension polymerisation in O/W 
emulsion  [69] 
Termosensitive PNIPAAm-
grafted PA microcapsules Interfacial polymerisation [70, 71] 
P(St-co-DMAEMA) hollow 
particles 
Suspension polymerisation in O/W 
emulsion [72-74] 
Colloidal 
assemblies 
Uniform assemblies of 
polystyrene microbeads 
Removal of water from S/W/O 
emulsion [33] 
  
Table 3: Some premix membrane emulsification investigations reported so far. 
 
Membrane 
material System 
Mean 
pore size, 
dm (µm) 
Product 
emulsion 
Mean droplet 
size and span 
Flux  
(m3m-2h-1) Ref. 
Tubular SPG Cross flow 2.7 and 4.2 O/W 1.4-2.1dm ,  span=0.4-0.62 0.03-3.5 [88]  
Flat PTFE Dead end 1.0 O/W and W/O 2-4.1dm Up to 9  [19] 
Flat PTFE 
Dead end 
with phase 
inversion 
1.0 O/W and W/O 2.8-4.0dm 1-5.5 [20] 
Flat PTFE 
Dead end, 
multipass 
(n=1-3) 
1.0 O/W 1.2-2.6dm span=0.55-0.9 2-18 [22] 
Flat cellulose 
acetate Dead end 
0.2, 0.45, 
0.8 and 3.0 W/O/W 1.0-3.5 dm Not given [27] 
Flat 
polycarbonate 
Dead end, 
multipass 
(n=1-18) 
0.33, 0.38, 
0.44, 0.6 
and 1.0 
O/W ≤ 1.6dm for n > 12 0.2-0.6 [26]  
Tubular SPG 
Dead end 
multipass 
(n=3) 
1.1 S/O/W 0.9dm 1.6 [41] 
Tubular SPG 
Dead end, 
multipass 
(n=1-5) 
10.7 W/O/W 0.41-1.2dm span=0.28-0.6 0.8-37 [92] 
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Table 4: Some case studies on using direct membrane emulsification for single emulsion 
productions published after 1999. 
 
M E M B R A N E P R O D U C T     E M U L S I O N  
Material Mean pore size 
Mean droplet 
size Type Formulation Ref. 
Hypothetical with 
porosity less than 
1.2-1.5 % 
5 µm 33 µm*  O/W Equilibrium interfacial  tension of 30 mN/m [97] 
Microengineered 
silicone nitride 
microsieve 
7 µm 52-250 µm  O/W 
oil phase: HD coloured with 
Sudan red 
water phase: water + 1% 
Tween 20 
[7], [28] 
Microengineered 
silicone nitride 
microsieve 
4.8 µm 34-100 µm O/W 
oil phase: HD 
water phase: water + 0.1-10 
% Tween 20 
[98] 
SPG 1, 10 µm 6-10.9 µm CV=11-23%  O/W 
oil phase: HD + St + DVB 
water phase: water + PVA + 
SLS 
[99] 
SPG 1, 2.1, 3.2 
µm 3-300 µm O/W 
oil phase: HD or soybean oil 
water phase: water + 0.02-2 
% Tween 20 or 0.01-3 % Na-
CAS or 1 % BLG or mixed 
[100] 
Coated α-alumina 
and zirconia 
0.1, 0.5 
µm 0.5-12 µm O/W 
oil phase: suflower oil 
water phase: water + 1 % 
SDS or 0.02-0.5 % β-
CAS/11S soya globulin 
[12] 
Sol-gel porous 
glass (sol-gel PG) 0.6 µm 3 µm W/O 
oil phase: Tl + Span 20 
water phase: aqueous 
colloidal silica Snowtex N 
[14] 
Polypropylene 
hollow fibers 0.4 µm 
0.25-1.9 µm 
span=1.1-2.1 W/O 
oil phase: mineral oil Velocite 
no. 3 + 2.5-10 % PGPG 90 
water phase: demineralized 
water 
[18] 
Polycarbonate 10 µm 20-150 µm CV=20-50% O/W 
oil phase: pure soybean oil or 
soybean oil + 2 % TOMAC 
water phase: water + 0.3 wt.% 
SDS or 1 % PGFE or 1 % 
Tween 20 
[25] 
Polyamide hollow 
fibers 10 nm 
1.87 µm 
CV=33% O/W 
oil phase: pure IO or IO + 
naproxen methyl ester 
water phase: phosphate buffer 
pH 7.00 + 0.1-0.2 % SDS + 
0.4-0.8 % PVA 
[8] 
Straight-through 
silicon 
microchannels 
17 µm 
39-170 µm** 
CV=2.5-40%  
for SDS and 
Tween 20 
O/W 
oil phase: pure soybean oil or 
soybean oil + 2 % TOMAC 
water phase: water + 1 wt.% 
SDS or 1 % CTMABr or 1 % 
Tween 20 
[30] 
*The value calculated using computational fluid dynamics (CFD). 
**The value at the upper limit was obtained in the “continuous outflow” zone.  
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Table 5: Some investigations on one-stage suspension polymerisation in O/W emulsion 
prepared by membrane emulsification*.  
 
Polymer Emulsion formulation Membrane and product Ref. 
Polystyrene 
(PSt) 
DP: St, Hp, and BPO 
CP: Water, PVA, SLS, and 
NaNO2 
Membrane: 1.0, 1.4, and 2.9 µm SPG 
Droplets: de = 6-21 µm, CVe = 5-20 % 
Spheres: ds = 8-12 µm, CVs = 9-16 % 
[54] 
PASt 
DP: Xl/DD mixture, ASt, DVB, 
and BPO  
CP: Doubly distilled water, 
SDS, PVA, and Na2SO4  
Membrane: 1 µm SPG 
Droplets: Not given 
Spheres: ds = 3-5 µm 
[113] 
P(St-co-DVB) DP: 4-MP, St, DVB, and PSt CP: Water, PVA, and NaCl 
Membrane: Stainless steel with 100 and 
150 µm laser drilled pores 
Droplets: de = 100-300 µm 
Spheres: ds = 124 µm 
[15] 
P(St-co-DVB) 
particles with 
toner additives 
DP: St, DVB, E-81, SPBS, 
ADVN, and AIBN  
CP: Water, SDS, and PVA 
Membrane: 1.0, 2.0, and 3.0 µm SPG 
Droplets: de = 2-7.3 µm 
Spheres: ds = 1.9-6.1 µm 
[78] 
Carbon black 
embedded P(St-
co-BA) 
DP: St, BA, Carbon black 
particles, Span 60, and BPO 
CP: Water, SLS, and PVA 
Membrane: 2.9 µm SPG 
Droplets: Not given 
Spheres: ds = 5.8 µm, CVs = 11 % 
[115] 
P(St-co-MMA) 
DP: St, DVB, MMA, EGDMA, 
HD, and BPO 
CP: Water, PVA, SLS, Na2SO4, 
and HQ 
Membrane: 1.4 µm SPG 
Droplets: de = 9-16 µm, CVe = 12-16 % 
Spheres: ds = 7-14 µm, CVs = 13-28 % 
[56] 
DOP plasticized 
P(St-co-MA), 
P(MMA-co-
MA), and P(St-
co-BMA)  
DP: St, MMA, MA, BMA, BA, 
BMA, DOP, and BPO or 
ADVN 
CP: Water, PVA, SDS, Na2SO4, 
and NaNO2 or PDA 
Membrane: 0.5 and 0.9 µm SPG 
Droplets: de = 4-9 µm, CVe = 8-40 % 
Spheres: ds = 3-7 µm, CVs = 10-27 % 
[119] 
P(butadiene-co-
styrene) 
DP: Tl, BR, St, DVB, CA, and 
BPO 
CP: Water and SLS 
Membrane: 1.6 µm SPG 
Droplets: Not given 
Spheres: ds = 4.5-5.2 µm, CVs = 9-16 % 
[120] 
P(St-co-
DMAEMA) 
DP: HD, St, DMAEMA, and 
ADVN 
CP: Water with PVP or PVA, 
SLS, and HQ, DAP or NaNO2 
Membrane: 1.4 µm SPG 
Droplets: Not given 
Spheres: ds = 5-11 µm, CVs = 10-15 % 
[74] 
P(St- co-DVB- 
co-TMPTMA) 
containing PIP 
DP: St, DVB, BANI-M, 4-MP, 
TMPTMA, and ADVN 
CP: Water, PVA, SLS, NaNO2, 
and Na2SO4 
Membrane: 1.4 µm SPG 
Droplets: Not given 
Spheres: ds = 8-14 µm, CVs = 11-42 % 
[117] 
P(meth)acrylate 
DP: Tl and/or Hp, ADVN, MP 
and various combinations of 2-
EHA, 2-EHMA, EGDMA, 
MMA, LA, LMA, and CHA 
CP: water, PVA, SLS, and 
NaNO2 
Membrane: 0.9, 5.2, and 9.2 µm SPG 
Droplets: de = 28-37 µm, CVe = 10-40 % 
(using 5.2 µm SPG) 
Spheres: ds = 5-45 µm, CVs = 10-17 % 
(using 0.9-9.2 µm SPG) 
[121] 
PUU-VP, PUU-
P(St-co-
EGDMA), 
PUU-P(St-co-
TMPTMA) 
DP: Xl, PU prepolymer, VP or 
St and EGDMA or TMPTMA, 
and ADVN 
CP: Water, MST-1, NaNO2, 
Na2SO4, and SLS 
Membrane: 5.2 µm SPG 
Droplets: Not given 
Spheres: ds = 15-21 µm, CVs = 9-18 % 
[57] 
*de = mean size of emulsified droplets; ds = mean size of polymer microspheres; DP = disperse (oil) phase; 
CP = continuous (aqueous) phase. 
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Table 6: Investigations on direct (one-stage) suspension polymerisation in W/O and 
W/O/W emulsions prepared by SPG membrane emulsification.  
 
Polymer Emulsion formulation Membrane and product Ref. 
Composite  
PSt-PAAm  
W/O/W emulsion: 
Internal water phase: water, 
AAm, MBAAm, and KPS 
Oil phase: St, DVB or EGDMA, 
ADVN, Span 85, and PSt 
External water phase: water, 
PVP, SLS, Na2SO4, HQ, and 
NaNO2 or DAP 
Membrane: 5.2 µm SPG 
Droplets: de = 20-22 µm, CVe = 7-11 % 
Spheres: ds = 15-22 µm, CVs = 8-40 % 
[58] 
P(AAm-co-AA) 
and PAAm 
hydrogel 
W/O emulsion: 
Disperse phase.: AAm, (AA), 
MBAAm, TMEDA, and NaCl 
Continuous phase: CHx, AIBN, 
and SUNSOFT818H 
Membrane: 0.33, 0.73, 1.1 and 1.7 µm 
hydrophobic SPG 
Droplets: Not given 
Spheres: ds = 1.4-7.4 µm, Span = 0.35-
0.98 
[59, 
123] 
 
 
 
Table 7: Investigations on direct suspension polymerisation in O/W emulsions produced by 
microfabricated channel devices. 
 
Polymer Emulsion formulation Device and product Ref. 
PDVB 
Disperse phase: DVB with 2 
% BPO 
Continuous phase: Water with 
0.2 % SDS 
Silicon MCs: 30 µm MC width, 16 µm  
MC depth, 98 and 240 µm terrace length  
Droplets: de = 75 and 90 µm, CVe = 2.8 and 
2.3 % 
Spheres: ds = 69 and 87 µm, CVs = 4.1 and 
4.8 % 
[124] 
PDVB 
Disperse phase: DVB with 2 
% BPO 
Continuous phase: Water with 
0.1-0.2 % SDS 
Silicon MCs: 3-12 µm MC width, 1-2 µm 
MC depth, 98 and 5-25 µm terrace length  
Droplets: de = 4 and 10 µm, CVe = 4.4 and 
9.1 % (for 0.2 % SDS solution) 
Spheres: ds = 3 and 9 µm, CVs = 6 and 7 % 
[125] 
Poly(HDDA) 
Disperse phase: HDDA with 1 
wt. % DAROCUR® 1173 
Continuous phase: Water with 
2 % PVA 
Quartz glass microfluidic device with a T-
junction: monomer channel 120 × 30 µm, 
aqueous phase channel 220 × 30 µm. 
Droplets: de = 30-120 µm, CVe = 1-2% 
Spheres: ds = 30-120 µm, CVs = 1-2 % 
[32] 
Bichromal 
poly(IBOA) 
Disperse phase: IBOA with 2 
% initiator and 10 % carbon 
black (for black monomer) or 
TiO2 (for white monomer) 
Continuous phase: Water with 
2 % PVA 
Quartz glass microfluidic device with a Y-
junction and two coflowing channels: 
feed channels 120 × 100 µm, outlet channel 
220 × 100 µm. 
Droplets: de = 90-190 µm, CVe = 0.3-0.7 % 
Spheres: ds = 90-190 µm, CVs = 0.3-0.7 % 
[32] 
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Table 8: Investigations on droplet swelling method (two-stage suspension polymerisation) 
for production of polymer microspheres. The primary (seed) emulsion was prepared by 
SPG membrane emulsification. 
 
 
Polymer 
 
 
Formulation 
 
 
Membrane and Product 
 
 
Ref. 
 
Poly(methyl 
methacrylate) 
Primary O/W emulsion: 
DP: Bz, Hp, HD, and BPO 
CP: Water, PVA, SLS, and 
NaNO2 
Secondary O/W emulsion: 
MMA (and EGDMA) in aqueous 
SLS solution 
Membrane: 0.5 µm SPG 
Seed droplets: de = 2-9 µm, CVe = 
10-11 % 
Polymer spheres: ds =2.4-37 µm, 
CVs = 9-15 % 
[60] 
Poly(styrene-co-
divinylbenzene) 
Primary O/W emulsion: 
DP: Different mixtures of DVB, 
St, HD, LA, Hp, and BPO 
CP: Water, PVA, SLS, (Na2SO4 
and DHBSP) 
Secondary O/W emulsion: 
Various mixtures of St, DVB, 
GMA, HA, AA, IA, Bz, DCB, 
TCB in aqueous SLS solution 
Membrane: 5.2 µm SPG 
Seed droplets: de = 26-36 µm, CVe = 
8.6-38 % 
Swollen droplets: de = 32-111 µm, 
CVe = 8.3-55 % 
Polymer spheres: ds = 32-102 µm, 
CVs = 7.9-28 % 
[61] 
Composite PSt-
PMMA with 
higher content of 
HEMA  
Primary O/W emulsion: 
DP: Different mixtures of St, 
DVB, HD, Bz, and BPO 
CP: Water, PVA, SLS, Na2SO4, 
and HQ. 
Secondary O/W emulsion: 
St, HEMA or MMA, HEMA, 
EGDMA (and HA) in aqueous 
solution of SLS (and NaNO2) 
Membrane: SPG, pore size not given 
Swollen droplets: swelling ratio was 
1.6-8 
Polymer spheres: ds = 8-18 µm, CVs 
= 9.1-15.5 % 
[129] 
Polymers 
including PIP 
Primary O/W emulsion: 
DP: Different mixtures of BANI-
M, St, BA, 2-EHA, and LA 
CP: Water, PVA, and SLS 
Secondary O/W emulsion: 
MMA, MA, EGDMA, HA, OA, 
and IA in aqueous SLS solution 
Membrane: 1.4 µm SPG 
Swollen droplets: de = 8 µm, CVe = 
11.7 % 
Polymer spheres: ds = 6 µm, CVs = 
10.6 % (for the given swollen 
droplets) 
[117] 
P(St-co-
PEGMMA) and 
PEGPMMA 
Primary O/W emulsion: 
DP: t-BPP, (St), and Bz 
CP: Water, PVA, and SDS 
Secondary O/W emulsion: 
PEGMMA, EGDMA, Bz, Bac, 
EA, and BuOH in aqueous 
solution of PVA and SDS 
Membrane: 9 µm SPG 
Seed droplets: de = 29.6 µm 
Swollen droplets: de = 60.8 µm 
Polymer spheres: ds = 50.0 µm, CVs 
= 7.64 % 
[112] 
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Table 9: Some recent investigations on preparation of polymer microspheres and 
microcapsules by membrane emulsification and subsequent organic solvent evaporation. 
 
 
 
Microcapsule 
 
 
Formulation 
 
 
Membrane and Product 
 
 
Ref. 
 
Fe3O4 embedded 
P(St-co-AA),  
P(St-co-BA), and 
SBR 
DP: Fe3O4 particles, Tl or 
CHCl3, P(St-co-AA) or P(St-
co-BA) or SBR 
CP: Water, PVA, and SDS 
Membrane: 1.4, 5.2, and 9.5 µm SPG 
Fe3O4 in Tl: de = 6-75 µm, CVe = 11-27 
%; ds = 5-39 µm, CVs = 14-50 % 
Fe3O4 in CHCl3: de = 8-30 µm, CVe = 
21-94 %; ds = 7-25 µm, CVs = 24-101 % 
[68] 
PLA 
biodegradable 
DP: DCM, PLA, and HD or 
LOH 
CP: Water, PVA, and SLS 
Membrane: 5.2 µm SPG 
Droplets: de = 14-38 µm, CVe = 11-35 % 
Spheres: ds = 9-24 µm CVs = 12-31 % 
[65] 
PSt-PMMA 
composite 
DP: DCM, PMMA, PSt, and 
LOH 
CP: Water, PVA, and SLS 
Membrane: 5.2 µm SPG 
Droplets: de = 11-30 µm, CVe = 13-17 % 
Spheres: ds ≈ 10 µm 
[64] 
TiO2 embedded 
P(St-co-AA),  
P(St-co-2-EHA), 
and P(St-co-
DMAEMA)  
DP: Tl, ML, HD, HA, TiO2 
powder, Disperbyk-111 or 
180, P(St-co-AA) or P(St-
co-2-EHA) or P(St-co-
DMAEMA) 
CP: Water, PVA, and SDS 
Membrane: 1.4, 2.8, 5.2, 7.0 and 9.5 μm 
SPG 
Droplets: de = 13-23 µm 
Spheres: ds = 2-20 µm, CVs = 30-66 % 
[66, 67] 
PUU 
DP: Xl and PU prepolymers 
CP: Water, PVP or MST-1, 
PVA, and SLS 
Membrane: 5.2 µm SPG 
Droplets: de = 7-30 µm, CVe = 10 % 
Spheres: ds = 5-20 µm, CVs = 8 % 
[62] 
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Figure captions 
 
 
Figure 1: Some products of membrane and microchannel emulsification. 
 
Figure 2: Flowsheet for manufacture of some particulates via membrane emulsification 
routes. 
 
Figure 3: Schematic diagram of membrane emulsification methods. 
 
Figure 4: Membrane emulsification systems for controlling hydrodynamic conditions near 
the membrane surface. 
 
Figure 5:  Evolution of hexadecyl palmitate in a cross flow membrane crystallization 
(XMC) process. 
  
Figure 6: Flowsheet for manufacture of three kinds of solid lipid microcarriers for nutrient 
or drug controlled release using SPG membrane emulsification. The dashed area represents 
the temperature-controlled operations at 80 °C (above a melting point of oil). 
 
Figure 7: The SEM photographs of a W/O solid lipid microcarrier for oral administration 
of anticancer drug irinotecan hydrochloride (CPT-11). The microcarrier was prepared by a 
temperature-controlled SPG membrane emulsification, followed by cooling and filtration 
of solidified W/O/W emulsion. Reproduced with permission from ref. [105]. 
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Figure 8: Polydivinylbenzene microspheres, made by Sekisui Chemical Industries Co. Ltd. 
as spacers for LCD devices, prepared by membrane emulsification and subsequent 
suspension polymerisation. Reproduced with permission from ref. [34]. 
 
Figure 9: Polymer beads made by interfacial polymerisation using a perforated spinning 
stainless steel membrane. 
 
Figure 10: General flowsheet for manufacture of polymer microspheres by two-stage 
suspension polymerisation incorporating membrane emulsification. 
 
Figure 11: Schematic illustration of the preparation route and the controlled release 
behavior of the thermoresponsive microcapsule: (a) oil droplet; (b) core-shell microcapsule 
with a porous shell; (c) hollow particle with a porous shell; (d) hollow particle with 
PNIPAAm gates; (e) loading an active agent into the microcapsule; (f) active agent-loaded 
microcapsule; and (g) releasing the active agent from the microcapsule. Reproduced with 
permission from ref. [71]. 
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